Vaxlogic LLC entered the industry of Commercial Medical Research in 2013 and has grown to employ 1 to 4 people, generating an annual revenue of $0 to $49.999. The NAICS classifies this business under the code 541712, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Richard Spaziano by calling (401) 738-0215 during business hours. You can also write to the business’ Single Location at 85 Toll Gate Road, Warwick, Rhode Island RI 02886. You can also visit the company’s website at pharmlogic.co. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Vaxlogic LLC |
Representative: | Richard Spaziano |
Place of Business: | 85 Toll Gate Road, Warwick, RI 02886 |
Contact Number: | (401) 738-0215 |
Website: | pharmlogic.co |
Type of Service: | Commercial Medical Research |
SIC Number: | 8731 |
NAICS Number: | 541712 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2013 |
Income/Year: | $0 to $49.999 |
Laborers: | 1 to 4 |
Share This Company: |
Vaxlogic LLC is a company operating from Kent, Rhode Island providing professional Commercial Medical Research and relevant B2B variables. It was founded in 2013 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 541712 as Commercial Medical Research.
With a current employee count of 1 to 4, Vaxlogic LLC has gone to report making $0 to $49.999 per annum on its journey towards growth. This company invites you to contact its representative Richard Spaziano at (401) 738-0215 for related queries, or to locate its Single Location using the coordinates 41.699214,-71.465492.
The Single Location can also be found at the street address 85 Toll Gate Road in Warwick, Rhode Island 02886 and can be engaged online through the company website at pharmlogic.co, the company Twitter , and Facebook page .